SEC Form 4 · accession 0000920465-17-000018
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lakhmir S Chawla
Officer — Chief Medical Officer
Period of report
Jan 4, 2017
Accepted (ET)
Jan 6, 2017 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.19 | Jan 4, 2017 | A | 64,100 | A | — | Jan 4, 2027 | Common Stock | 64,100 | 64,100 | D |
Explanation of responses
- F1This option represents a right to purchase a total of 64,100 shares of the Issuer's Common Stock one quarter of which shall be fully vested and exercisable on January 4, 2018, with the remaining 48,075 shares vesting monthly thereafter over the next three years.